Acebutolol Hydrochloride
Product Images NDC 10135-630

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Acebutolol Hydrochloride (NDC 10135-630). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Structural Formula For Acebutolol HCl, Usp Is A Selective, Hydrophilic Beta-adrenoreceptor Blocking Agent With Mild Intrinsic Sympathomimetic Activity For Use In Treating Patients With Hypertension And Ventricular Arrhythmias. It Is Marketed In Capsule Form For Oral Administration. Acebutolol HCl Capsules, Usp Are Provided In Two Dosage Strengths Which Contain 200 mg Or 400 mg Of Acebutolol As The Hydrochloride Salt. The Inactive Ingredients Present Are D&c Red 28, D&c Yellow 10, Fd&c Blue 1, Fd&c Red 40, Gelatin, Maize Starch, Povidone, Stearic Acid And Titanium Dioxide. (Acebutolol Hydrochloride Capsules 01)

Chemical structure of Acebutolol Hydrochloride showing its molecular composition and arrangement, including functional groups and hydrochloride salt.*

FDA Label Image

The Following Table Shows The Frequency Of Treatment-related Side Effects Derived From Controlled Clinical Trials In Patients With Hypertension, Angina Pectoris, And Arrhythmia. These Patients Received Acebutolol, Propranolol, Or Hydrochlorothiazide As Monotherapy, Or Placebo. (Acebutolol Hydrochloride Capsules 02)

Data table presenting the percentage of body system adverse reactions volunteered and elicited in U.S. studies for four groups: Acebutolol, Propranolol, Hydrochlorothiazide, and Placebo, across various categories including cardiovascular, central nervous system, dermatologic, gastrointestinal, genitourinary, musculoskeletal, respiratory, and special senses.*

FDA Label Image

The Incidence Of Drug-related Adverse Effects (volunteered And Solicited) According To Acebutolol Dose Is Shown Below. (data From 266 Hypertensive Patients Treated For 3 Months On A Constant Dose.) (Acebutolol Hydrochloride Capsules 03)

A table presenting adverse event percentages by body system for three different dosages of Acebutolol Hydrochloride: 400 mg/day (N=132), 800 mg/day (N=63), and 1200 mg/day (N=71). It covers cardiovascular, gastrointestinal, musculoskeletal, central nervous system, respiratory, skin, special senses, and genitourinary systems.*

FDA Label Image

Principal Display Panelndc 10135-0630-01acebutolol Hydrochloridecapsules, Usp200 mg100 Capsulesrx Only (Acebutolol Hydrochloride Capsules 04)

Label for Acebutolol Hydrochloride Capsules, USP 200 mg by Marlex Pharmaceuticals, Inc. The label shows a NDC number 10135-0630-01, stating the package contains 100 capsules. It includes storage instructions, a barcode, and notes that the capsules are sealed for protection and for prescription use only.*

FDA Label Image

Principal Display Panelndc 10135-0631-01acebutolol Hydrochloridecapsules, Usp400 mg100 Capsulesrx Only (Acebutolol Hydrochloride Capsules 05)

Acebutolol Hydrochloride Capsules, USP 400 mg by Marlex Pharmaceuticals, Inc. The label shows it contains 100 capsules and includes storage instructions, dosage information, and a warning to keep out of reach of children. The label also features the NDC code 10135-0631-01 and states the product is sealed for protection and Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.